Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
It is designed for single-dose use only
The three recommended injection sites are the abdomen (at least 2 inches from the navel), the front of the thigh, and the back of the upper arm
We will focus on measures that actually matter how you feel, how you move, how your clothes fit, and objective metrics where appropriate (waist circumference, strength, activity) rather than the scale alone
Key Takeaways Retatrutide is a triple agonist binding GIP, GLP-1 and glucagon receptors simultaneously, a mechanism absent from all MHRA-authorised incretin therapies The 32mg pen format minimises wastage in early-phase protocols and supports typical titration schedules from 0.5mg to 4mg per administration Every unit ships with batch-level traceability, HPLC purity documentation and a certificate of analysis Retatrutide holds no MHRA marketing authorisation and is supplied strictly for laboratory research use UK orders ship free via tracked Royal Mail within 13 working days
420 West Mountain St
US$ 25.25
US$ 23.17
US$ 24.69
